George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLivermore Regulatory News (LIV)

Share Price Information for Livermore (LIV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.00
Bid: 28.00
Ask: 32.00
Change: -0.90 (-2.91%)
Spread: 4.00 (14.286%)
Open: 30.90
High: 0.00
Low: 0.00
Prev. Close: 30.90
LIV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Nominated Adviser

27 Apr 2022 11:00

RNS Number : 5387J
Livermore Investments Group Limited
27 April 2022
 

LIVERMORE INVESTMENTS GROUP LIMITED

("Livermore" or the "Group")

Appointment of Nominated Adviser

The directors of Livermore are pleased to announce the appointment of Strand Hanson Limited as its Nominated Adviser and Financial Adviser with immediate effect. Arden Partners plc will continue to act as Broker to the Company.

Further to the announcements by Arden Partners Plc on 11 and 14 April 2022 regarding the loss of its nominated adviser status upon the completion of its recommended takeover, the Company has appointed Strand Hanson Limited as its nominated adviser. Given the timing of the completion of the recommended takeover of Arden Partners plc, the London Stock Exchange plc has agreed that subject to initial due diligence being undertaken, Strand Hanson Limited has until 5pm on 27 July 2022 to complete its full due diligence.

There can be no guarantee on the outcome of the full due diligence and its impact on Strand Hanson Limited's decision to continue to act as nominated adviser. Accordingly, in such circumstances there is a risk that if Strand Hanson Limited does not continue to act as nominated adviser following completion of its full due diligence and the Company has not found an alternative nominated adviser, the Company's AIM securities may be suspended pursuant to AIM Rule 1. If within one month of that suspension, the Company has failed to appoint a replacement nominated adviser, the admission of its AIM securities will be cancelled.

Notwithstanding the extension of time provided in respect of completing full due diligence obligations at engagement, Strand Hanson Limited will continue to be subject to all the ongoing nominated adviser responsibilities under the AIM Rules for Nominated Advisers.

 

For further information please contact: 

Livermore Investments Group Limited

Gaurav Suri

+41 (0) 43 344 3200

Strand Hanson Limited (Financial and Nominated Adviser)

Ritchie Balmer, James Spinney

+44 (0) 20 7409 3494

Arden Partners plc (Broker)

Richard Johnson, Antonio Bossi

 +44 (0) 20 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPSELSUWEESELL
Date   Source Headline
18th Dec 20234:23 pmRNSInterim dividend exchange rate
6th Dec 20234:10 pmRNSFurther re Interim Dividend
21st Nov 20237:00 amRNSInterim Dividend
29th Sep 20237:00 amRNSInterim Results
29th Aug 202311:30 amRNSResult of AGM
3rd Aug 20237:55 amRNSCorrection of AGM date
29th Jun 202311:00 amRNSPosting of Report and Accounts and Notice of AGM
22nd May 20237:05 amRNSDirector transfer of shares
22nd May 20237:00 amRNSFinal Results
24th Jan 20231:07 pmRNSChange of Adviser
30th Sep 20227:00 amRNSInterim Results
23rd Aug 202212:01 pmRNSResult of Annual General Meeting
18th Jul 202210:58 amRNSCompletion of Nominated Adviser Due Diligence
30th Jun 202210:14 amRNSPosting of Report and Accounts and Notice of AGM
30th May 20227:00 amRNSFinal Results
27th May 20222:36 pmRNSAIM Rule 17 – Schedule 2(g) update
27th Apr 202211:00 amRNSAppointment of Nominated Adviser
26th Apr 202210:27 amRNSAIM Rule 17 - historic disclosure
5th Jan 20227:00 amRNSDividend Declaration
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
29th Sep 20214:30 pmRNSInterim Results
25th Aug 20212:02 pmRNSResult of Annual General Meeting
30th Jun 20217:00 amRNSAnnual Report and Notice of AGM
26th May 20217:00 amRNSFinal Results
10th May 20214:41 pmRNSSecond Price Monitoring Extn
10th May 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20212:52 pmRNSInterim Dividend Declaration
18th Feb 20219:00 amRNSDirector dealing, Share buyback and TVR
28th Sep 20209:30 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2020
25th Aug 202011:37 amRNSResult of AGM
19th Aug 20207:00 amRNSAGM - change of location
8th Jul 20207:00 amRNSAGM - revised Forms of Proxy and Direction
26th Jun 202011:36 amRNSPosting of Report and Accounts and Notice of AGM
20th May 20207:00 amRNSFinal Results
9th Apr 20207:00 amRNSCOVID-19 update
31st Dec 201912:05 pmRNSAnnouncement of Interim Dividend
17th Sep 20197:00 amRNSInterim Statement
21st Aug 20197:00 amRNSResult of AGM
7th Aug 20199:19 amRNSEstablishment of a branch
28th Jun 20199:12 amRNSPosting of Report and Accounts
22nd May 20197:00 amRNSAnnual Financial Report
14th Feb 20197:00 amRNSAppointment of Director
29th Oct 20187:00 amRNSPrice Monitoring Extension
25th Sep 20187:00 amRNSInterim Results
21st Aug 201812:08 pmRNSResult of AGM
29th Jun 201812:03 pmRNSPosting of Report and Accounts
29th May 20187:00 amRNSAnnual Financial Report
17th Jan 201812:34 pmRNSDividend Declaration
28th Sep 20178:20 amRNSCancellation of treasury shares
27th Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.